Sanctuary Advisors LLC Makes New $9.82 Million Investment in Danaher Corporation $DHR

Sanctuary Advisors LLC purchased a new position in Danaher Corporation (NYSE:DHR) in the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 51,553 shares of the conglomerate’s stock, valued at approximately $9,820,000.

A number of other hedge funds have also made changes to their positions in the stock. High Note Wealth LLC boosted its stake in Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares in the last quarter. First Command Advisory Services Inc. raised its stake in shares of Danaher by 4.4% in the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after buying an additional 47 shares in the last quarter. GW&K Investment Management LLC raised its stake in shares of Danaher by 8.4% in the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock worth $138,000 after buying an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC lifted its holdings in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after buying an additional 48 shares during the period. Finally, SOL Capital Management CO boosted its stake in Danaher by 2.7% during the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock valued at $430,000 after buying an additional 50 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Down 1.7%

DHR stock opened at $215.18 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a market capitalization of $151.27 billion, a P/E ratio of 38.22, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company’s 50 day simple moving average is $196.49 and its 200-day simple moving average is $192.39.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business posted $0.77 EPS. The company’s revenue was up 5.5% on a year-over-year basis. As a group, equities research analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research analyst reports. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, July 15th. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Wells Fargo & Company reduced their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Finally, TD Cowen dropped their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.